Compounded semaglutide vs brand name: what is the difference and is it safe?

Short answer

• Brand-name semaglutide (examples: Ozempic and Wegovy from Novo Nordisk; Rybelsus is the oral semaglutide tablet) are FDA‑approved, manufactured under strict standards and studied in clinical trials for specific doses and indications.
• Compounded semaglutide is made by a pharmacy that mixes or repackages the drug into a formulation or dose not commercially available. Compounded products are not individually FDA‑approved and have higher uncertainty about quality, potency and sterility — so they carry additional safety and reliability risks.

What the difference means in practice

• Regulatory status: Brand products (Ozempic, Wegovy, Rybelsus) are FDA‑approved with labeled dosing, expiration/stability data and required manufacturing controls. Compounded versions are produced under state pharmacy and compounding rules and are not reviewed/approved by the FDA as a finished product.
• Quality control: Commercial manufacturers run batch testing, validated sterility and potency assays. Compounding pharmacies vary in capability; reputable ones do testing, but standards and oversight are not identical.
• Dosage and formulation: Compounds are used to create nonstandard concentrations, single-dose vials, or preservative-free versions. That can be useful, but also increases the chance of dosing errors or stability problems.
• Cost & access: Compounded semaglutide may be cheaper or easier to obtain locally when brand product is unavailable, but that cost saving comes with tradeoffs noted above.

Safety issues to be aware of

• Same pharmacologic adverse effects apply (nausea, vomiting, constipation, dehydration, gallbladder problems, rare pancreatitis risk, risk of thyroid C‑cell tumors seen in rodents, and hypoglycemia when combined with insulin/sulfonylureas).
• Additional risks with compounded products: incorrect dose or potency, contamination/sterility failures (especially with injectables), shorter or uncertain shelf life, and unknown impurities. There have been cases historically of outbreaks linked to contaminated compounded injectables.
• Buying from unverified online sources or overseas suppliers increases risk of counterfeit or contaminated product.

When compounded semaglutide might be considered

• A prescriber has a clear, documented medical reason for a nonstandard dose or a special formulation (e.g., allergy to an excipient, need for very small incremental dosing that brand pens don’t allow).
• When brand product is unavailable and a prescriber weighs risks/benefits with the patient.

How to reduce risk if you and your clinician decide to use compounded semaglutide

• Use only a reputable, accredited compounding pharmacy. Ask whether the pharmacy is PCAB‑accredited or follows USP <797>/<800> standards for sterile compounding. (PCAB = Pharmacy Compounding Accreditation Board.)
• Ask for a Certificate of Analysis (COA) or lab testing showing assay/potency and sterility testing for the lot you receive.
• Confirm beyond-use/expiration dating and storage requirements in writing.
• Get clear written dosing instructions and have your prescriber monitor you closely for efficacy and side effects.
• Don’t buy injectable drugs from foreign websites or marketplaces that don’t require a prescription. Report adverse events to your prescriber and to the FDA MedWatch program.

Recommendations

• Prefer an FDA‑approved product when appropriate: Ozempic (semaglutide injection for type 2 diabetes), Wegovy (semaglutide injection at higher doses for chronic weight management), or Rybelsus (oral semaglutide tablet) — all made by Novo Nordisk. These have known dosing regimens, established manufacturing quality and labeled safety information.
• If your prescriber believes compounding is necessary, use a PCAB‑accredited compounding pharmacy and request COA/sterility data. If you need help finding an accredited pharmacy, your state board of pharmacy or your prescriber can recommend one.

Bottom line FDA‑approved semaglutide products are safer from a manufacturing, testing and regulatory standpoint. Compounded semaglutide can be appropriate in limited, clinically justified situations but carries greater risks; if used, select a high‑quality, accredited compounder and work closely with your prescriber.

If you want, tell me why you’re asking (cost, availability, a specific dose, pregnancy, allergies) and I can give more tailored guidance or name resources (patient assistance programs, how to verify a compounding pharmacy, or manufacturers’ programs).